PremiumThe FlyIspire Technology files application with FDA for age-verification component Ispire Technology Earnings Call: Mixed Results Amid Strategic Moves Ispire Technology Reports Quarterly Financial Results PremiumThe FlyIspire Technology price target lowered to $9 from $12.50 at Roth MKM Ispire Technology, IKE Tech announce pre-PMTA submission meeting with FDA Ispire Technology Sees Profit Growth Amid Revenue Drop PremiumThe FlyIspire Technology signs five-year master distributor agreement with ANDS Ispire Technology management to meet virtually with Roth MKM ISPR Earnings Report this Week: Is It a Buy, Ahead of Earnings? 
